Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,8102 USD | -3,55% | -2,19% | +42,14% |
Attività
Numero di dipendenti: 40
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark Rothera
CEO | Chief Executive Officer | 62 | 19/09/22 |
Melody Burcar
DFI | Director of Finance/CFO | 41 | 01/09/22 |
Chief Tech/Sci/R&D Officer | - | - | |
Darrel Cohen
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/08/23 |
Ayman El-Guindy
CTO | Chief Tech/Sci/R&D Officer | - | 06/07/21 |
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Ashleigh Barreto
IRC | Investor Relations Contact | - | 01/10/21 |
Corporate Officer/Principal | - | 06/07/21 | |
Patric Nelson
PRN | Corporate Officer/Principal | - | 06/07/21 |
Cheryl A. Madsen
LAW | General Counsel | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Thomas Darcy
BRD | Director/Board Member | 74 | 01/02/21 |
Barry Simon
BRD | Director/Board Member | 69 | 03/03/21 |
Mark Rothera
CEO | Chief Executive Officer | 62 | 19/09/22 |
Roger Pomerantz
CHM | Chairman | 67 | 01/06/20 |
Flavia Borellini
BRD | Director/Board Member | 65 | 14/08/21 |
Jane Barlow
BRD | Director/Board Member | 63 | 14/08/21 |
Stephen Rubino
BRD | Director/Board Member | 65 | 03/03/21 |
Sam Murphy
BRD | Director/Board Member | - | 01/01/19 |
Jane Chung
BRD | Director/Board Member | 53 | 10/08/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 39 272 434 | 38 184 370 ( 97,23 %) | 0 | 97,20 % |
Azione B | 0 | 10 248 | 0 | 0 |
Coordinate società
Viracta Therapeutics, Inc.
2533 South Coast Highway 101 Suite 210
92007, Cardiff
+
http://www.viracta.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+42,14% | 31,82 Mln | |
+25,69% | 47,86 Mrd | |
+46,90% | 41,42 Mrd | |
-3,46% | 40,66 Mrd | |
-6,20% | 28,92 Mrd | |
+9,17% | 25,55 Mrd | |
-20,42% | 19,27 Mrd | |
+0,17% | 12,15 Mrd | |
+28,07% | 12,14 Mrd | |
-1,24% | 11,99 Mrd |
- Borsa valori
- Azioni
- Azione VIRX
- Società Viracta Therapeutics, Inc.